Invion Limited Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest, by Alistair Bennallack, was filed 19 Jun 2026.
Invion Limited: what insiders have been doing
Invion Limited is a listed company. Its insiders report their share dealings to ASX. Over the twelve months to 18 October 2026, 4 filings were filed, from 2 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 2 purchases. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 senior executive.
Compared with its exchange (1,605 companies, median 4 filings), a count of 4 filings is typical. Over the whole record (from 2026), the tally stands at 2 purchases and no sales.
The clock since the last published purchase (19 June 2026) now reads 142 days.
This summary is built from ASX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -17.1%Entry A$0.04 · Close 16 Oct 2026 A$0.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended June 2025 · cache
- ShareASXISIN AU000000IVX4ASX:2924-03123678-2A1690788
- ShareASXISIN AU000000IVX4ASX:2924-03123676-2A1690785
- 1,352,497 sharesShareASXISIN AU000000IVX4ASX:2924-03101906-2A1678222Canonical exit: 10 Sept 2026 (T+90)
- 12,963 sharesShareASXASX:2924-03088858-2A1671494Canonical exit: 9 Aug 2026 (T+90)
4 of 4 declarations
About Invion Limited
Invion Limited is an Australian Securities Exchange listed company focused on developing innovative cancer treatments. It specializes in using nanomedicine technology to enhance patient outcomes.